Drugs For Malaria Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

Malaria is a disease caused by the plasmodium parasite, transmitted by the bite of infected mosquitoes. Symptoms are chills, fever, and sweating, usually occurring a few weeks after being bitten. People traveling to areas where malaria is common typically take protective drugs before, during, and after their trip. Treatment includes antimalarial drugs.

MARKET SCOPE

The "Global Drugs for Malaria Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Drugs for Malaria market with detailed market segmentation by drug class and distribution. The report provides key statistics on the market status of the leading Drugs for Malaria market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•   Based on drug class the market is segmented as, quinine, chloroquine, proguanil, mefloquine, pyrimethamine, and others.
  
•   Based on distribution the market is segmented as, hospital pharmacy, retail pharmacy, e-commerce, and other distribution channels.
  

MARKET DYNAMICS

Drivers:

•   Rising prevalence of malaria.
  
•   The increasing outbreak of plasmodium parasite.
  
•   Increasing geriatric population.
  
•   Government policies and social campaigns for malaria awareness are expected to spur market growth during the forecast period.
  

Restraints:

•   Whereas, the high cost of treatment is expected to restrain the market growth during the forecast period.
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South and Central America. The Drugs for Malaria market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South and Central America after evaluating political, economic, social and technological factors affecting the Drugs for Malaria market in these regions.

IMPACT OF COVID-19 ON DRUGS FOR MALARIA MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the Drugs for Malaria market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market acquisitions, and partnership & collaborations. These activities have paved the way for the expansion of the business and customer base of market players. The market payers from the Drugs for Malaria market are anticipated to lucrative growth opportunities in the future with the rising demand for Drugs for Malaria in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Drugs for Malaria market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•   ALVIZIA HEALTHCARE PVT. LTD.
  
•   BAYER AG
  
•   F. HOFFMANN-LA ROCHE LTD
  
•   GLAXOSMITHKLINE PLC
  
•   IPCA LABORATORIES LTD.
  
•   MERCK AND CO., INC
  
•   NOVARTIS AG
  
•   PFIZER INC.
  
•   SUN PHARMACEUTICAL INDUSTRIES LTD.
  
•   ZYDUS CADILA.
  

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Drugs For Malaria Report Scope